The 2023 Tandem Meetings will feature both in-person and virtual programing to allow you to choose the experience that best fits your schedule, budget and needs. No matter how you choose to join us, all registered attendees will be able to view session recordings at the conclusion of the 2023 Tandem Meetings. Attendees will have access to receive continuing education credits for up to 30 days…
Thomas Fox, MbChB, MD, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses an individualized approach to assessing potential risks of bone marrow…
Alex Rampotas, MD, University College London, London, UK, summarizes a talk on the role of donor lymphocyte infusion (DLI) in the post-allogenic stem cell transplant…
Rémy Duléry, MD, PhD, Saint-Antoine Hospital, Paris, France, outlines the main side effects associated with post-transplant cyclophosphamide (PTCy) as prophylaxis for graft-versus-host disease (GvHD) following…
Shahram Kordasti, MSc, MD, PhD, King’s College London, London, UK, shares his thoughts on the potential therapeutic capacity of immune checkpoint inhibitors (ICIs) in patients…
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Curtis Lachowiez, MD, Oregon Health & Science University, Portland, OR, discusses promising combination approaches for overcoming venetoclax resistance in acute myeloid leukemia (AML). He mentions…
Thomas Fox, MbChB, MD, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses CRISPR-based autologous gene therapy for treating primary immunodeficiency disorders (PIDs).…
Shahram Kordasti, MSc, MD, PhD, King’s College London, London, UK, shares his thoughts on the potential therapeutic capacity of immune checkpoint inhibitors (ICIs) in patients…
Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon, summarizes a talk on the current standard of care, outcomes, and unmet…
VJHemOnc is excited to share an exclusive case study exploring the current approach to the diagnosis and classification of follicular lymphoma.
